Literature DB >> 35290496

Left main coronary artery compression by dilated pulmonary artery in pulmonary arterial hypertension: a systematic review and meta-analysis.

Ruxandra Badea1, Dan M Dorobantu2,3, Mansour T A Sharabiani4, Lucian M Predescu5,6, Ioan M Coman5,6, Carmen Ginghina5,6.   

Abstract

OBJECTIVE: Pulmonary arterial hypertension (PAH) can lead to left main coronary artery compression (LMCo), but data on the impact, screening and treatment are limited. A meta-analysis of LMCo cases could fill the knowledge gaps in this topic.
METHODS: Electronic databases were searched for all LMCo/PAH studies, abstracts and case reports including pulmonary artery (PA) size. Restricted maximum likelihood meta-analysis was used to evaluate LMCo-associated factors. Specificity, sensitivity and accuracy of PA size thresholds for diagnosis of LMCo were calculated. Treatment options and outcomes were summarized.
RESULTS: A total of five case-control cohorts and 64 case reports/series (196 LMCo and 438 controls) were included. LMCo cases had higher PA diameter (Hedge's g 1.46 [1.09; 1.82]), PA/aorta ratio (Hedge's g 1.1 [0.64; 1.55]) and probability of CHD (log odds-ratio 1.22 [0.54; 1.9]) compared to non-LMCo, but not PA pressure or vascular resistance. A 40 mm cut-off for the PA diameter had balanced sensitivity (80.5%), specificity (79%) and accuracy (79.7%) for LMCo diagnosis, while a value of 44 mm had higher accuracy (81.7%), higher specificity (91.5%) but lower sensitivity (71.9%). Pooled mortality after non-conservative treatment (n = 150, predominantly stenting) was 2.7% at up to 22 months of mean follow-up, with 83% survivors having no angina at follow-up.
CONCLUSION: PA diameter, PA/aorta ratio and CHD are associated with LMCo, while hemodynamic parameters are not. Data from this study support that a PA diameter cut-off between 40 and 44 mm can offer optimal accuracy for LMCo screening. Preferred treatment was coronary stenting, associated with low mid-term mortality and symptom relief. Diagnosis and management of left main coronary artery compression (LMCo) in patients with pulmonary arterial hypertension (PAH).
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

Entities:  

Keywords:  Left main coronary artery compression; Left main coronary artery intervention; Pulmonary arterial hypertension; Pulmonary artery dilatation; Pulmonary hypertension prognosis; Systematic review

Mesh:

Year:  2022        PMID: 35290496     DOI: 10.1007/s00392-022-01999-z

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  18 in total

1.  Likelihood of left main coronary artery compression based on pulmonary trunk diameter in patients with pulmonary hypertension.

Authors:  Sonia M F Mesquita; Claudia R P Castro; Nana M Ikari; Sérgio A Oliveira; Antonio Augusto Lopes
Journal:  Am J Med       Date:  2004-03-15       Impact factor: 4.965

2.  Left Main Coronary Artery Extrinsic Compression in Patients With Pulmonary Arterial Hypertension: Technical Insights and Long-Term Clinical Outcomes After Stenting.

Authors:  Francesco Saia; Gianni Dall'Ara; Antonio Marzocchi; Fabio Dardi; Massimiliano Palazzini; Alessandra Manes; Nevio Taglieri; Cinzia Marrozzini; Andrea Rinaldi; Nazzareno Galiè
Journal:  JACC Cardiovasc Interv       Date:  2019-02-11       Impact factor: 11.195

3.  Left Main Coronary Artery Compression in Patients With Pulmonary Arterial Hypertension.

Authors:  Fernando Alfonso; Fernando Rivero
Journal:  J Am Coll Cardiol       Date:  2017-06-13       Impact factor: 24.094

Review 4.  Complications leading to sudden cardiac death in pulmonary arterial hypertension.

Authors:  Eftychia A Demerouti; Athanassios N Manginas; George D Athanassopoulos; George T Karatasakis
Journal:  Respir Care       Date:  2012-12-27       Impact factor: 2.258

5.  Extrinsic compression of left main coronary artery by aneurysmal pulmonary artery in severe pulmonary hypertension: its correlates, clinical impact, and management strategies.

Authors:  Ozgur Yasar Akbal; Cihangir Kaymaz; Ibrahim Halil Tanboga; Aykun Hakgor; Fatih Yilmaz; Sevim Turkday; Cem Dogan; Seda Tanyeri; Durmus Demir; Zubeyde Bayram; Mahmut Bugrahan Cicek; Rezzan Deniz Acar; Nihal Ozdemir
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2018-11-01       Impact factor: 6.875

6.  Left Main Coronary Artery Compression in Patients With Pulmonary Arterial Hypertension and Angina.

Authors:  Nazzareno Galiè; Francesco Saia; Massimiliano Palazzini; Alessandra Manes; Vincenzo Russo; Maria Letizia Bacchi Reggiani; Gianni Dall'Ara; Enrico Monti; Fabio Dardi; Alessandra Albini; Andrea Rinaldi; Enrico Gotti; Nevio Taglieri; Cinzia Marrozzini; Luigi Lovato; Maurizio Zompatori; Antonio Marzocchi
Journal:  J Am Coll Cardiol       Date:  2017-06-13       Impact factor: 24.094

7.  Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era.

Authors:  Marc Humbert; Olivier Sitbon; Ari Chaouat; Michèle Bertocchi; Gilbert Habib; Virginie Gressin; Azzedine Yaïci; Emmanuel Weitzenblum; Jean-François Cordier; François Chabot; Claire Dromer; Christophe Pison; Martine Reynaud-Gaubert; Alain Haloun; Marcel Laurent; Eric Hachulla; Vincent Cottin; Bruno Degano; Xavier Jaïs; David Montani; Rogério Souza; Gérald Simonneau
Journal:  Circulation       Date:  2010-06-28       Impact factor: 29.690

8.  Detection of mechanical complications related to the potential risk of sudden cardiac death in patients with pulmonary arterial hypertension by computed tomography.

Authors:  Sang-Eun Lee; Ji Hyun Im; Ji Min Sung; In-Jeong Cho; Chi Young Shim; Geu-Ru Hong; Namsik Chung; Jo Won Jung; Hyuk-Jae Chang
Journal:  Int J Cardiol       Date:  2017-05-25       Impact factor: 4.164

Review 9.  Optimising the management of pulmonary arterial hypertension patients: emergency treatments.

Authors:  M Delcroix; R Naeije
Journal:  Eur Respir Rev       Date:  2010-09

Review 10.  ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association.

Authors:  Vallerie V McLaughlin; Stephen L Archer; David B Badesch; Robyn J Barst; Harrison W Farber; Jonathan R Lindner; Michael A Mathier; Michael D McGoon; Myung H Park; Robert S Rosenson; Lewis J Rubin; Victor F Tapson; John Varga; Robert A Harrington; Jeffrey L Anderson; Eric R Bates; Charles R Bridges; Mark J Eisenberg; Victor A Ferrari; Cindy L Grines; Mark A Hlatky; Alice K Jacobs; Sanjay Kaul; Robert C Lichtenberg; Jonathan R Lindner; David J Moliterno; Debabrata Mukherjee; Gerald M Pohost; Robert S Rosenson; Richard S Schofield; Samuel J Shubrooks; James H Stein; Cynthia M Tracy; Howard H Weitz; Deborah J Wesley
Journal:  Circulation       Date:  2009-03-30       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.